Back to results
US 2025/0152529 A1Published application
Method of escalating sotalol hydrochloride dosing
AssigneeAltaThera Pharmaceuticals LLC
InventorsJohn Charin Somberg, Brandon Ira Kashfian, Janos Molnar
Life of this patent
Estimating the term…
Abstract
The present invention provides novel methods of initiating and escalating sotalol hydrochloride in patients in need thereof.
Claims12
A method of escalating sotalol hydrochloride, dosing comprising:
- a. escalating an existing sotalol concentration of a subject to a higher level by administering an intravenous (IV) dose of 105 mg sotalol hydrochloride over a period of 1 hour to the subject, wherein the subject had symptomatic atrial fibrillation or atrial flutter and is currently in sinus rhythm;
- and
- b. after completion of the IV dose, administering oral dosing of one or more oral dose of sotalol hydrochloride to the subject in an amount of 160 mg;
- wherein the subject is discharged from the hospital 24 hours after IV initiation.
1 more element
(canceled)
Dependencies are inferred from the claim text.